Studies Closed to Enrollment
| Clinical Trial | Study Result Published |
|---|---|
| A4 Study 3-year prevention trial | |
| AbbVie 2-year infusion study | |
| ADMET-2 Study to treat apathy in AD | |
| Aerobic exercise and Cognitive Training in Older Adults | |
| ASCEND 2-year study of cardiovascular influences on AD | |
| AVID Autopsy A 6-mth study to evaluate new MRI techniques | Avid Autopsy |
| BIOGEN-FTD 1 year observational study | |
| Calibrex 1-year study of the relationship between high blood pressure and AD | |
| CEDAR 1-year study on the effects of candesartan vs placebo in mild cognitive impairment and Alzheimer's disease | |
| CREAD A 2 year infusion study to slow Alzheimer's disease (AD) progression | |
| Atomoxetine Clinical Trial: for people with Mild Cognitive Impairment (MCI) | |
| Neuroimaging & Biomarkers Study - ADNI: Normal Aging, Mild Cognitive Impairment & Early Alzheimer's Disease | Over 100 Study publications |
| Daybreak A 78-week study of a drug designed to slow Alzheimer's disease (AD) progression by lowering beta amyloid production | |
| EARLY 5-year prevention trial | |
EMERALD Montelukast Therapy for Alzheimer's disease | |
| EMERGE A 12-month infusion study to slow progression of cognitive and functional impairment | |
| Exercise and Motor Dexterity | |
| EXERT Study of effects of aerobic exercise on cognition | |
| Generation 2 5 - 7 year prevention trial for healthy participants | |
| Racial Disparities in ADL's | Results pending |
| Registry for Remembrance An initiative to increase awareness & participation in neurology research | |
| DIAN Study 2-year prevention trial | |
MAP Metformin in Alzheimer's disease Prevention | |
| NeuroVision 2-day study that involves imaging of the retina | |
| Right Frontal Activity in Older Adults: Does it Help or Hurt Word Retrieval? | |
| Effects of Perceptual Interference on Memory in Mild Cognitive Impairment (MCI) | |
| SERENE 3-month study aimed at reducing agitation and aggression in Alzheimer's disease | |
| Tau Imaging (GN30009) 18-month observational imaging study | |
| Tele-Savvy A 6-week free on-line education program for informal caregivers | |
| TRIAD A 4-month study aimed at reducing agitation in Alzheimer's disease | |
| VASCULAR 2-year observational study of the relationship between vascular factors and memory loss | |
| Alzheimer's Disease Neuroimaging Initiative - GO Pre-Mild Cognitive Impariment Study | |
| BAN2401 A 18 month infusion study to slow Alzheimer's disease (AD) progression | |
| EPOCH A clinical trial testing a new treatment for Alzheimer's disease (AD) | |
| Nerve Growth Factor: Gene Therapy Surgical Intervention Trial | Results pending. |
| Lewy Body Disease | |
| Cognitive Rehabilitation of Memory in Mild Cognitive Impairment Examines changes in learning, memory, and brain activity | |
| Cognitive Aging Project | |
| Natural History of FTD Subtypes | |
| Memory Training in Mild Cognitive Impairment | Results pending |
| Starshine | |
| MK8931-019 2-year trial for treatment of MCI | |
| DHA, an Omega 3 Fatty Acide, in Slowing the Progression of Alzheimer's Disease | Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial |
| RAGE (Receptor for Advanced Glycation Endproducts) Inhibitor Study | PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease |
| Caregiver Opportunities for Optimizing Lifestyles: A Research Opportunity for African American Caregivers (COOL-AD) | |
| Development of a Biomarker for FTLD-TDP and FTLD-Tau | |
| Cognitive Decline in Patients with Amyotrophic Lateral Sclerosis (ALS) | |
| Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP) | Quetiapine for agitation or psychosis in patients with dementia and parkinsonism. Kurlan R, Cummings J, Raman R, Thal L for the Alzheimer's Disease Cooperative Study Group Neurology. 2007 April 24: 68; 1356-1363 |
| Vitamins to Slow Alzheimer's Disease (Homocysteine Study) (VITAL) | High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial |
| Mild Cognitive Impairment Study Aricept, Vitamin E or Placebo | Vitamin E and donepezil for the treatment of mild cognitive impairment. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ; Alzheimer's Disease Cooperative Study Group, N Engl J Med. 2005 Jun 9; 352(23):2379-88. Epub 2005 Apr 13 |
| TauRx 1 year study for treatment of bvFTD | |
| The Role of Sleep in Cognitive Decline in Normal Aging | |
| TOMMORROW 5-year prevention trial | |
| VASCULAR VASCULAR studies the role of circulatory function on memory and the risk of Alzheimer's disease. | |
| HEART 8-month study of an FDA-approved blood pressure medicine in the African-American population Learn more about the HEART study |